Logo
Menu
  • Home
  • Practice Areas
    • Medical Malpractice LawHelping New York Medical Malpractice, Personal Injury Cases
    • Close
  • New York Injury News
  • Press release
    • Injury News
    • Motor Vehicle Accidents
    • Personal Injury Accidents
    • Construction Accidents
    • Medical Malpractice
    • Premises Liability
    • Product Liability
    • Work Related Fire Fighter Deaths
    • Wrongful Death
    • Close
  • Ask A Lawyer
  • Free Case Evaluation
  • Sitemap

Home » Injury News » FDA Approves Non-Opioid Drug for Treatment of Heroine, Narcotic Addictions

FDA Approves Non-Opioid Drug for Treatment of Heroine, Narcotic Addictions

New Source: JusticeNewsFlash.com
10/14/2010 // West Palm Beach, FL, US // Sandra Quinlan // Sandra Quinlan

West Palm Beach, FL—The U.S. Food and Drug Administration (FDA) has OK’d use of a non-opioid drug that appears promising in the field of heroine and narcotic addiction treatment. With approximately 810,000 Americans addicted to heroine and another 1.85 million addicted to opioid painkillers, according to the National Institute on Drug Abuse, newly approved Vivitrol may help users get clean, and stay clean, according to an October 13, 2010 USA Today report.

According to information provided, Vivitrol is a long-lasting type of naltrexone, a substance intended to block opioids. While a single injection of the treatment drug costs a whopping $1,100, a recent study suggests the benefits may be worth it.

The FDA approved Vivitrol for use in the treatment of alcohol addition in 2006. Given that Russia remains the only other country to approve the drug for such use, a study involving 250 patients was conducted there.

There are two other drugs used in the treatment of narcotic and opioid addictions, methadone and bupenorphrine (Suboxone).

According to Nora Volkow, director of the drug abuse institute, “There are many treatment programs that really oppose using methadone and bupenorphrine … I predict that naltrexone may be acceptable.” Russia reportedly refused to approve those drugs for addiction treatment.

In the Russian study, 70 percent of patients who were administered six monthly shots of Vivitrol, as opposed to a placebo, did not relapse. Patients who received the Vivitrol were apparently twice as likely to stop using narcotics then those given the placebo.

“I was concerned that the patients would not go back for their monthly injections, but they did, which was surprising,” said Volkow, noting that the drug appeared to lessen cravings for narcotics.

Westborough, Mass. resident and former heroine addict, T.J. Voller, 29, apparently found a doctor who agreed to treat him with Vivitrol. Voller tried bupenorphrine before, but claimed it had an infrequent success rate.

Voller was administered eight monthly injections of Vivitrol and alleged, “It takes the cravings away… I’ve had (heroine) in front of my face and haven’t had the urge to do it. It shocked the hell out of me.” Voller is now employed and attends college.

Legal News Reporter: Sandra Quinlan.

Media Information:

Address:
Phone: (866) 598-1315
Url: Sandra Quinlan: West Palm Beach Injury News News Source: JusticeNewsFlash.com – Press Release Distribution

It's only fair to share...Pin on Pinterest
Pinterest
Tweet about this on Twitter
Twitter
Share on LinkedIn
Linkedin
Share on Facebook
Facebook
Email this to someone
email
Print this page
Print
October 21, 2010   injurynewsreporter
Injury News
×

  • Wheat Ridge Harassment: Car Salesman Sent Woman Lewd Text Messages
  • Cedar Falls, IA Man Killed in Illinois Demolition Accident

Recent News and Press Coverage

  • Todd Stager, Esteemed SEO for Lawyers Expert, Embarks on a New Journey with His Own SEO Firm March 11, 2024
  • Attorney Dan Powell Examines the Financial Challenges of Not Having a Living Trust: Implications for Business Owners February 16, 2024
  • Adam P. Boyd Leads Innovative Masterclass on Strategies for Law Firm Growth February 14, 2024
  • David Dardashti Donates to Expand Research on Sexual Violence Among Children and Develop Prevention Protocol. January 29, 2024
  • A Queens County Supreme Court jury rendered a verdict for $7 million In Medical Negligence Case December 1, 2023
  • Record-Breaking $700,000 Verdict by Mezrano Law Firm Redefines Justice in Personal Injury Cases November 30, 2023
  • The Law Office of Richard Roman Shum Unveils Comprehensive Guide on New York Divorce Laws October 12, 2023
  • Brooklyn Estate Planning Attorney Yana Feldman Offers Free Services for Israel-bound Volunteers October 12, 2023
  • Google Drops FAQ Rich Snippets so Custom Legal Marketing Released a Video to Help Lawyers Understand Why October 5, 2023
  • Bronx Injury Attorneys Explain How Damages Are Calculated August 22, 2023
  • ZeroRisk Cases, Inc. Utilizes Cutting-Edge Technology to Target High-Quality Plaintiffs in Talcum Powder Litigation August 15, 2023
  • ZeroRisk Cases, Inc. Unveils Advanced Website Platform and Digital Marketing Strategy for Increased Law Firm Growth August 15, 2023
  • The Search Engine Domination Society Achieves a 300% Increase in Client Calls for NYC Personal Injury Lawyer August 11, 2023
  • Federal Tax Credits ERC Updates and Releases New Informational Videos about ERC July 6, 2023
  • Who is Liable for Dooring Accidents? Bronx E-bike Attorney Glenn A. Herman Explains July 4, 2023
  • Weizhen Tang Announces Publication of Law and Justice: My Struggle During His 2026 Mayoral Campaign July 4, 2023
  • Enhancing Data Compliance with AdvisorVault: Heritage Brokerage’s 17a-4 Trusted Partner July 3, 2023
  • Attorney Beau Harlan: The Champion of Justice Unveils Comprehensive Legal Services for Vancouver, WA and Portland, OR June 28, 2023
  • The Legal Process for Motor Vehicle Accidents in New York City June 2, 2023
  • NYC Bicycle Accident Lawyer Explains Winning an Accident Claim March 20, 2023

Archives

  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • August 2023
  • July 2023
  • June 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • October 2022
  • September 2022
  • July 2022
  • June 2022
  • May 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • July 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • December 1999
  • January 1970
New York Injury News
1512 Schorr Place
PMB #35071
Bronx, NY 10469
718-210-1007
Copyright © 2025 New York Injury News
Go to mobile version